The uses of GHS are documented in many studies
GLP-1 is contraindicated in patients including but not limited to: those with a personal or family history of medullary thyroid cancer, patients with multiple endocrine neoplasia type 2, patients with a hypersensitivity reaction to GLP-1 or any of the product components, as well as patients with pancreatitis, kidney disease, diabetic retinopathy or gallbladder disease
A number of studies on the side effects of this insecticide have been reported, including neurotoxicity [11], allergy and immunosupression [12][14], cardiovascular [15] and reproductive side effects [16]
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: A systematic review
Yes, certain agents like semaglutide are FDA-approved for chronic weight management in people without diabetes